Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Tsuda

Showing results (341-350 of 477) with videos related to

Pageof 48
Sort By:
Cancer Science|July 13, 2012
Bcl-2, Bcl-6, and the International Prognostic Index are prognostic indicators in patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapyAkiko Miyagi Maeshima, Hirokazu Taniguchi, Suguru Fukuhara, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 10, 2012
Histological grading of ovarian clear cell adenocarcinoma: proposal for a simple and reproducible grouping system based on tumor growth architectureSohei Yamamoto, Hitoshi Tsuda, Hideyuki Shimazaki, et al.
Lung Cancer (Amsterdam, Netherlands)|December 7, 2010
The usefulness of mutation-specific antibodies in detecting epidermal growth factor receptor mutations and in predicting response to tyrosine kinase inhibitor therapy in lung adenocarcinomaYoshiki Kozu, Koji Tsuta, Takashi Kohno, et al.
Annals of Surgical Oncology|April 25, 2020
Clinical Significance of a Gene Signature Generated from Tumor Budding Grade in Colon CancerEiji Shinto, Yuichiro Yoshida, Yoshiki Kajiwara, et al.
BMC Cancer|June 11, 2008
Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancerShigeto Ueda, Hitoshi Tsuda, Hideki Asakawa, et al.
The Prostate|October 24, 2015
A pilot study of photoacoustic imaging system for improved real-time visualization of neurovascular bundle during radical prostatectomyAkio Horiguchi, Kazuhiro Tsujita, Kaku Irisawa, et al.
Abdominal Radiology (New York)|February 28, 2022
Magnetic resonance imaging findings of pure prostatic ductal adenocarcinomas: a case seriesHiromi Edo, Yasuyo Urase, Yoshiko Ueno, et al.
Molecular Oncology|May 12, 2020
Long non-coding NR2F1-AS1 is associated with tumor recurrence in estrogen receptor-positive breast cancersAnna Sanchez Calle, Tomofumi Yamamoto, Yumi Kawamura, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 1, 2006
Potential crosstalk between insulin-like growth factor receptor type 1 and epidermal growth factor receptor in progression and metastasis of pancreatic cancerShigeto Ueda, Kazuo Hatsuse, Hitoshi Tsuda, et al.
Japanese Journal of Clinical Oncology|September 10, 2011
Pfetin as a prognostic biomarker for gastrointestinal stromal tumor: validation study in multiple clinical facilitiesDaisuke Kubota, Hajime Orita, Akihiko Yoshida, et al.
Pageof 48

Showing results (341-350 of 477) with videos related to

Sort By:
Pageof 48
Cancer Science|July 13, 2012
Bcl-2, Bcl-6, and the International Prognostic Index are prognostic indicators in patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapyAkiko Miyagi Maeshima, Hirokazu Taniguchi, Suguru Fukuhara, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 10, 2012
Histological grading of ovarian clear cell adenocarcinoma: proposal for a simple and reproducible grouping system based on tumor growth architectureSohei Yamamoto, Hitoshi Tsuda, Hideyuki Shimazaki, et al.
Lung Cancer (Amsterdam, Netherlands)|December 7, 2010
The usefulness of mutation-specific antibodies in detecting epidermal growth factor receptor mutations and in predicting response to tyrosine kinase inhibitor therapy in lung adenocarcinomaYoshiki Kozu, Koji Tsuta, Takashi Kohno, et al.
Annals of Surgical Oncology|April 25, 2020
Clinical Significance of a Gene Signature Generated from Tumor Budding Grade in Colon CancerEiji Shinto, Yuichiro Yoshida, Yoshiki Kajiwara, et al.
BMC Cancer|June 11, 2008
Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancerShigeto Ueda, Hitoshi Tsuda, Hideki Asakawa, et al.
The Prostate|October 24, 2015
A pilot study of photoacoustic imaging system for improved real-time visualization of neurovascular bundle during radical prostatectomyAkio Horiguchi, Kazuhiro Tsujita, Kaku Irisawa, et al.
Abdominal Radiology (New York)|February 28, 2022
Magnetic resonance imaging findings of pure prostatic ductal adenocarcinomas: a case seriesHiromi Edo, Yasuyo Urase, Yoshiko Ueno, et al.
Molecular Oncology|May 12, 2020
Long non-coding NR2F1-AS1 is associated with tumor recurrence in estrogen receptor-positive breast cancersAnna Sanchez Calle, Tomofumi Yamamoto, Yumi Kawamura, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 1, 2006
Potential crosstalk between insulin-like growth factor receptor type 1 and epidermal growth factor receptor in progression and metastasis of pancreatic cancerShigeto Ueda, Kazuo Hatsuse, Hitoshi Tsuda, et al.
Japanese Journal of Clinical Oncology|September 10, 2011
Pfetin as a prognostic biomarker for gastrointestinal stromal tumor: validation study in multiple clinical facilitiesDaisuke Kubota, Hajime Orita, Akihiko Yoshida, et al.
Pageof 48